4//SEC Filing
Wolff Henry Ward 4
Accession 0001209191-19-034804
CIK 0001269021other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 5:06 PM ET
Size
6.3 KB
Accession
0001209191-19-034804
Insider Transaction Report
Form 4
Wolff Henry Ward
Director
Transactions
- Exercise/Conversion
Common Stock
2019-06-03$27.55/sh−2,000$55,104→ 0 total(indirect: By Trust)
Holdings
- 13,766
Common Stock
Footnotes (3)
- [F1]Subsequent to Reporting Person's acquisition of 5,000 shares through a cash exercise on March 12, 2019, Reporting Person transferred 2,000 shares into the Henry & Marian Wolff 1999 Revocable Trust for which Reporting Person is a trustee.
- [F2]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.13 to $27.98, inclusive. The Reporting Person undertakes to provide Portola Pharmaceuticals, Inc., any security holder of Portola Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
PORTOLA PHARMACEUTICALS INC
CIK 0001269021
Entity typeother
Related Parties
1- filerCIK 0001302390
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 5:06 PM ET
- Size
- 6.3 KB